Policies Index Comptroller Home UVA Documents Search

Policy: V.C.1

Issued: October 1, 2001

Owner: Office of Sponsored Programs

Latest Revision:



This policy is currently under revision at the University. Although the statements herein reflect enforced policy guidance, please contact the "Owner" listed above if you have questions about how this policy applies to your office. The statements herein are to be used as general guidance until the policy has been revised and added to the University Policy Directory. Thank you.

1.0 Purpose

This policy covers responsibilities for the billing and reimbursement of clinical trials in the case of "event-billing."

2.0 Policy [Top]

2.1 Accordance with other University Policies
Billing for clinical trials and the resulting reimbursements should be processed according to the the Clinical Trials Billing procedure ( ), and in accordance with the University policy which addresses the timely deposit of checks, Policy II.E.4, "Controlling Cash Items".

2.2 Oracle Responsibilities
In accordance with Oracle protocols, entry of invoices into OGM may only be made by the Office of Sponsored Programs.

2.3 Accounts Receivable
Deposits to credit grants may only be made by the centralized Accounts Receivable unit.

3.0 Definitions [Top]

"Event Billing" -- Event billing can be defined as an activity that takes place when an investigator or clinical coordinator submits a report to a sponsor. In the case of clinical trials, this triggers a payment based on the number of subjects involved in, for example, a drug study.

4.0 References [Top]

See also Policy II.E.4, "Controlling Cash Items."
See also Procedure 5-20, "Event Based Billing."

5.0 Approvals and Revisions [Top]


Maintained by University Comptroller
© 2001 by the Rector and Visitors of the University of Virginia